Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 37-44

  Hochberg, Marc C ^a   Martel Pelletier, Johanne ^b   Monfort, Jordi ^c   Möller, Ingrid ^d   Castillo, Juan Ramón ^e   Arden, Nigel ^f,g   Berenbaum, Francis ^h   Blanco, Francisco J ⁱ   Conaghan, Philip G ^j   Doménech, Gema ^k   Henrotin, Yves ^l,m   Pap, Thomas ⁿ   Richette, Pascal ^o,p   Sawitzke, Allen ^q   Souich, Patrick Du ^r   Pelletier, Jean Pierre ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HOSPITAL DEL MAR   (Spain)

^d Instituto Poal de Reumatologia   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ HOSPITAL JUAN CANALEJO   (Spain)

^j UNIVERSITY OF LEEDS   (United Kingdom)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l UNIVERSITY OF LIÈGE   (Belgium)

^m Princess Paola Hospital   (Belgium)

ⁿ UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^o UNIVERSITÉ PARIS DESCARTES   (France)

^p INSERM   (France)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^r UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CHONDROITIN SULFATE; GLUCOSAMINE; CYCLOOXYGENASE 2 INHIBITOR; DRUG COMBINATION;

ADULT; ALLERGIC REACTION; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DERMATITIS; DERMATITIS PSORIAFORM; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HELICOBACTER INFECTION; HUMAN; JOINT EFFUSION; JOINT STIFFNESS; JOINT SWELLING; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARALLEL DESIGN; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; CLINICAL TRIAL; COMPLICATION; DRUG COMBINATION; EDEMA; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; CELECOXIB; CHONDROITIN SULFATES; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EDEMA; FEMALE; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84954371655     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206792     Document Type: Article

References (41)

1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
2. Murray CJ, Vos T, Lozano R, et al. Disability-Adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
3. Smalley WE, Ray WA, Daugherty JR, et al. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995;141:539-45.
4. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
5. Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-Analyses of individual participant data from randomised trials. Lancet 2013;382:769-79.
6. Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 2004;12:269-76.
7. Morreale P, Manopulo R, Galati M, et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996;23:1385-91.
8. Reginster JY, Deroisy R, Rovati LC, et al. Long-Term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
9. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007;56:555-67.
10. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
11. Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12:389-99.
12. Bingham CO, Bird SR, Smugar SS, et al. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis. Osteoarthritis Cartilage 2008;16:1289-93.
13. Bingham CO, Sebba AI, Rubin BR, et al. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology 2007;46:496-507.
14. Bingham CO, Smugar SS, Wang H, et al. Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo. Rheumatology 2009;48:1122-7.
15. Rother M, Lavins BJ, Kneer W, et al. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis 2007;66:1178-83.
16. Schnitzer TJ, Kivitz A, Frayssinet H, et al. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: A 13-week prospective, randomized, multicenter study. Osteoarthritis Cartilage 2010;18:629-39.
17. Birbara C, Ruoff G, Sheldon E, et al. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Curr Med Res Opin 2006;22:199-210.
18. International Conference on Harmonization (ICH). ICH Harmonised Tripartite Guideline Topic E9: Statistical Principles for Clinical Trials. 1998. http://www.ema. europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002928.pdf
19. Committee for Proprietary Medicinal Products (CPMP). CPMP/EWP/482/99 Final. Points to consider on switching between superiority and non-inferiority. London: European Medicines Agency, 2000.
20. du Souich P. Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther 2014;142:362-74.
21. Calamia V, Ruiz-Romero C, Rocha B, et al. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther 2010;12:R138.
22. Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial. Mayo Clin Proc 1999;74:1095-105.
23. Henrotin Y, Lambert C. Chondroitin and glucosamine in the management of osteoarthritis: An update. Curr Rheumatol Rep 2013;15:361.
24. Lippiello L, Woodward J, Karpman R, et al. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res 2000 (381):229-40.
25. McCarty MF, Russell AL, Seed MP. Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis. Med Hypotheses 2000;54:798-802.
26. Orth MW, Peters TL, Hawkins JN. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine Vet J Suppl 2002(34):224-9.
27. Chan PS, Caron JP, Rosa GJ, et al. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 2005;13:387-94.
28. McKenna F, Borenstein D, Wendt H, et al. Celecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol 2001;30:11-18.
29. Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: A randomized, double-blind, placebo-controlled pilot study. Mil Med 1999;164:85-91.
30. Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000;8:343-50.
31. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55.
32. Porcheret M, Jordan K, Croft P, et al. Treatment of knee pain in older adults in primary care: development of an evidence-based model of care. Rheumatology 2007;46:638-48.
33. Bruyere O, Burlet N, Delmas PD, et al. Evaluation of symptomatic slow-Acting drugs in osteoarthritis using the GRADE system. BMC Musculoskelet Disord 2008;9:165.
34. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-Analysis. JAMA 2000;283:1469-75.
35. Reichenbach S, Sterchi R, Scherer M, et al. Meta-Analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007;146:580-90.
36. Hochberg MC, Zhan M, Langenberg P. The rate of decline of joint space width in patients with osteoarthritis of the knee: A systematic review and meta-Analysis of randomized placebo-controlled trials of chondroitin sulfate. Curr Med Res Opin 2008;24:3029-35.
37. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-Analysis. Bmj 2010;341: c4675.
38. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: A meta-Analysis. Rheumatol Int 2010;30:357-63.
39. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee. Evidence-based guideline.
40. National Institute for Health and Care Excellence. NICE Clinical Guideline 177. Osteoarthritis. Care and management in adults. 2014. http://publications.nice.org. uk/osteoarthritis-cg177
41. Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006;295:1152-60.